-
公开(公告)号:US20220089536A1
公开(公告)日:2022-03-24
申请号:US17418060
申请日:2019-12-23
Applicant: AQUAFIL S.P.A. , GENOMATICA INC.
Inventor: Michele CECCHETTO , Anacleto DAL MORO , Lauri Hannunpoika SUOMINEN , Michael JAPS
IPC: C07D201/08
Abstract: A new process for the production of epsilon caprolactam (CPL) from 6-aminocaproic acid (6-ACA) can be obtained either from traditional petro chemical processes or can be obtained from biochemical processes. With the proposed process, the reaction time for conversion of 6-aminocaproic acid to the Nylon 6 monomer is shorter and significant energy savings are possible which is advantageous for industrial scale production. The conversion of 6-aminocaproic acid to the Nylon 6 monomer runs at atmospheric pressure and in the final product epsilon caprolactam with no oligomers formation of significance is obtained.
-
公开(公告)号:US20220064679A1
公开(公告)日:2022-03-03
申请号:US17230782
申请日:2021-04-14
Applicant: Genomatica, Inc.
Inventor: Petronella Catharina Raemakers-Franken , Martin Schurmann , Axel Christoph Trefzer , Stefaan Marie Andre De Wildeman
IPC: C12P13/00 , C07C227/06 , C07D223/10 , C12P13/02 , C07D201/08
Abstract: The invention relates to a method for preparing 6-aminocaproic acid (hereinafter also referred to as ‘6-ACA’) using a biocatalyst. The invention further relates to a method for preparing ε-caprolactam (hereafter referred to as ‘caprolactam’) by cyclising such 6-ACA. The invention further relates to a host cell, a micro-organism, or a polynucleotide which may be used in the preparation of 6-ACA or caprolactam.
-
公开(公告)号:US11180780B2
公开(公告)日:2021-11-23
申请号:US15616841
申请日:2017-06-07
Applicant: Genomatica, Inc.
Inventor: Anthony P. Burgard , Mark J. Burk , Robin E. Osterhout , Priti Pharkya
IPC: C12N9/88 , C12N9/90 , C12P7/16 , C12N15/00 , C12P7/18 , C12N15/52 , C12N9/04 , C07C29/80 , C12N9/02 , C12N9/10
Abstract: A non-naturally occurring microbial organism includes a microbial organism having a 1,3-butanediol (1,3-BDO) pathway having at least one exogenous nucleic acid encoding a 1,3-BDO pathway enzyme expressed in a sufficient amount to produce 1,3-BDO. The pathway includes an enzyme selected from a 2-amino-4-ketopentanoate (AKP) thiolase, an AKP dehydrogenase, a 2-amino-4-hydroxypentanoate aminotransferase, a 2-amino-4-hydroxypentanoate oxidoreductase (deaminating), a 2-oxo-4-hydroxypentanoate decarboxylase, a 3-hydroxybutyraldehyde reductase, an AKP aminotransferase, an AKP oxidoreductase (deaminating), a 2,4-dioxopentanoate decarboxylase, a 3-oxobutyraldehyde reductase (ketone reducing), a 3-oxobutyraldehyde reductase (aldehyde reducing), a 4-hydroxy-2-butanone reductase, an AKP decarboxylase, a 4-aminobutan-2-one aminotransferase, a 4-aminobutan-2-one oxidoreductase (deaminating), a 4-aminobutan-2-one ammonia-lyase, a butenone hydratase, an AKP ammonia-lyase, an acetylacrylate decarboxylase, an acetoacetyl-CoA reductase (CoA-dependent, aldehyde forming), an acetoacetyl-CoA reductase (CoA-dependent, alcohol forming), an acetoacetyl-CoA reductase (ketone reducing), a 3-hydroxybutyryl-CoA reductase (aldehyde forming), a 3-hydroxybutyryl-CoA reductase (alcohol forming), a 4-hydroxybutyryl-CoA dehydratase, and a crotonase. A method for producing 1,3-BDO, includes culturing such microbial organisms under conditions and for a sufficient period of time to produce 1,3-BDO.
-
24.
公开(公告)号:US20210332393A1
公开(公告)日:2021-10-28
申请号:US17064404
申请日:2020-10-06
Applicant: Genomatica, Inc.
Inventor: Robin E. Osterhout , Anthony P. Burgard , Priti Pharkya , Stefan Andrae
IPC: C12P5/02 , C12P7/18 , C12N1/14 , C12N1/20 , C12P7/42 , C12P7/02 , C12P7/40 , C12N15/70 , C12N15/81 , C12P7/04 , C12P7/44 , C12P13/00 , C12P17/10
Abstract: The invention provides non-naturally occurring microbial organisms containing enzymatic pathways and/or metabolic modifications for enhancing carbon flux through acetyl-CoA. In some embodiments, the microbial organisms of the invention having such pathways also include pathways for generating reducing equivalents, formaldehyde fixation and/or formate assimilation. The enhanced carbon flux through acetyl-CoA, in combination with pathways for generating reducing equivalents, formaldehyde fixation and/or formate assimilation can, in some embodiments, be used for production of a bioderived compound. Accordingly, in some embodiments, the microbial organisms of the invention can include a pathway capable of producing a bioderived compound of the invention. The invention still further provides a bioderived compound produced by a microbial organism of the invention, culture medium having the bioderived compound of the invention, compositions having the bioderived compound of the invention, a biobased product comprising the bioderived compound of the invention, and a process for producing a bioderived compound of the invention.
-
公开(公告)号:US20210323900A1
公开(公告)日:2021-10-21
申请号:US17330026
申请日:2021-05-25
Applicant: Genomatica, Inc.
Inventor: Myong KO , Haibo WANG , Patricia J. COLE , Perry Y. LIAO , Simon LI
Abstract: The disclosure relates to downstream processing of fatty alcohol (FALC) and provides a novel purification method that provides FALC at high purity and yield.
-
公开(公告)号:US20210310033A1
公开(公告)日:2021-10-07
申请号:US17229543
申请日:2021-04-13
Applicant: Genomatica, Inc.
Inventor: Stephen B. DEL CARDAYRE , Andreas W. SCHIRMER , Myong KO , Haibo WANG
Abstract: The present disclosure relates to processes that combine microbial production of organic intermediates and subsequent synthetic transformation to provide compounds of industrial value, including compounds used in fragrances.
-
公开(公告)号:US11130944B2
公开(公告)日:2021-09-28
申请号:US16272303
申请日:2019-02-11
Applicant: Genomatica, Inc.
Inventor: Mathew Rude , Na Trinh , Andreas Schirmer , Jacob Gano
Abstract: The disclosure relates to acyl-ACP reductase (AAR) enzyme variants that result in improved fatty aldehyde and fatty alcohol production when expressed in recombinant host cells. The disclosure further relates to methods of making and using such AAR variants for the production of fatty alcohol compositions having particular characteristics.
-
公开(公告)号:US20210254030A1
公开(公告)日:2021-08-19
申请号:US16978629
申请日:2019-03-08
Applicant: Genomatica, Inc.
Inventor: Michael A. Noble , Kevin G. Hoff , Anna Lechner , Harish Nagarajan
Abstract: Described herein are prenyltransferases including non-natural variants thereof having at least one amino acid substitution as compared to its corresponding natural or unmodified prenyltransferases and that are capable of at least two-fold greater rate of formation of cannabinoids such as cannabigerolic acid, cannabigerovarinic acid, cannabigerorcinic acid, and cannabigerol, as compared to a wild type control. Prenyltransferase variants also demonstrated regioselectivity to desired cannabinoid isomers such as CDBA (3-GOLA), 3-GDVA, 3-GOSA, and CBG (2-GOL). The prenyltransferase variants can be used to form prenylated aromatic compounds, and can be expressed in an engineered microbe having a pathway to such compounds, which include 3-GOLA, 3-GDVA, 3-GOSA, and CBG. 3-GOLA can be used for the preparation of cannabigerol (CBG), which can be used in therapeutic compositions.
-
公开(公告)号:US20210171987A1
公开(公告)日:2021-06-10
申请号:US17074017
申请日:2020-10-19
Applicant: Genomatica, Inc.
Inventor: Jay D. KEASLING , Zhihao HU , Chris SOMERVILLE , George CHURCH , David BERRY , Lisa C. FRIEDMAN , Andreas SCHIRMER , Shane BRUBAKER , Stephen B. DEL CARDAYRE
Abstract: Compositions and methods for production of fatty alcohols using recombinant microorganisms are provided as well as fatty alcohol compositions produced by such methods.
-
公开(公告)号:US20210147881A1
公开(公告)日:2021-05-20
申请号:US16912409
申请日:2020-06-25
Applicant: Genomatica, Inc.
Inventor: Mark J. Burk , Anthony P. Burgard , Jun Sun , Robin E. Osterhout , Priti Pharkya
Abstract: The invention provides non-naturally occurring microbial organisms having a butadiene pathway. The invention additionally provides methods of using such organisms to produce butadiene.
-
-
-
-
-
-
-
-
-